Evidence map›Paper›PMID 38288551›Full record

ArticleNanoscale horizons2024

Selenium-silk microgels as antifungal and antibacterial agents.

Elizabeth G Wiita, Zenon Toprakcioglu, Akhila K Jayaram, Tuomas P J Knowles

Open access · hybridAbstract read
In one paragraph

Article in Nanoscale horizons, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elizabeth G WiitaCentre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Lenseld Road, Cambridge CB2 1EW, UK. tpjk2@cam.ac.uk.ORCID 0000-0003-2416-5339
Zenon ToprakciogluCentre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Lenseld Road, Cambridge CB2 1EW, UK. tpjk2@cam.ac.uk.ORCID 0000-0003-1964-8432
Akhila K JayaramCentre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Lenseld Road, Cambridge CB2 1EW, UK. tpjk2@cam.ac.uk.
Tuomas P J KnowlesCentre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Lenseld Road, Cambridge CB2 1EW, UK. tpjk2@cam.ac.uk.ORCID 0000-0002-0016-3008
University of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance is a leading threat to global health. Alternative therapeutics to combat the rise in drug-resistant strains of bacteria and fungi are thus needed, but the development of new classes of small molecule therapeutics has remained challenging. Here, we explore an orthogonal approach and address this issue by synthesising micro-scale, protein colloidal particles that possess potent antimicrobial properties. We describe an approach for forming silk-based microgels that contain selenium nanoparticles embedded within the protein scaffold. We demonstrate that these materials have both antibacterial and antifungal properties while, crucially, also remaining highly biocompatible with mammalian cell lines. By combing the nanoparticles with silk, the protein microgel is able to fulfill two critical functions; it protects the mammalian cells from the cytotoxic effects of the bare nanoparticles, while simultaneously serving as a carrier for microbial eradication. Furthermore, since the antimicrobial activity originates from physical contact, bacteria and fungi are unlikely to develop resistance to our hybrid biomaterials, which remains a critical issue with current antibiotic and antifungal treatments. Therefore, taken together, these results provide the basis for innovative antimicrobial materials that can target drug-resistant microbial infections.

Indexed as

Anti-Infective AgentsMicrogelsSeleniumAnimalsAnti-Bacterial AgentsAntifungal AgentsBacteriaFungiMammalsSilkAnti-Bacterial AgentsAntifungal AgentsAnti-Infective AgentsMicrogelsSeleniumSilk

Identifiers

PMID38288551
PMCPMC10962633
OpenAlexW4390973759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.